​

Funding Round

Series A - Flore by Sun Genomics

Series A - Flore by Sun Genomics

Investment Firm

Overview

Sun Genomics provides personalized probiotic solutions based on AI and whole-genome sequencing of the microbiome.

Announced Date

Jun 29, 2020

Closed on Date

Sep 16, 2020

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Pangaea Ventures

Pangaea Ventures

Pangaea Ventures is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

5

Investor Name
Participant InvestorEmerging Technology Partners
Participant InvestorDanone Manifesto Venture
Participant InvestorHuman Longevity
Participant InvestorPangaea Ventures
Participant InvestorSOSV

Round Details and Background

Flore by Sun Genomics raised $9250000 on 2020-06-29 in Series A

Sun Genomics provides personalized probiotic solutions based on AI and whole-genome sequencing of the microbiome.

Company Funding History

9

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 08, 2022
Convertible Note - Flore by Sun Genomics
1-undefined
Nov 23, 2022
Series B - Flore by Sun Genomics
3-undefined
Sep 26, 2019
Non Equity Assistance - Flore by Sun Genomics
1-undefined
Dec 19, 2023
Series B - Flore by Sun Genomics
2-undefined

Recent Activity

There is no recent news or activity for this profile.